Postradioiodine Graves' management: The PRAGMA study
(2022)
Journal Article
Perros, P., Basu, A., Boelaert, K., Dayan, C., Vaidya, B., Williams, G. R., …Karavitaki, N. (2022). Postradioiodine Graves' management: The PRAGMA study. Clinical Endocrinology, https://doi.org/10.1111/cen.14719
Objective: Thyroid status in the months following radioiodine (RI) treatment for Graves' disease can be unstable. Our objective was to quantify frequency of abnormal thyroid function post-RI and compare effectiveness of common management strategies.... Read More about Postradioiodine Graves' management: The PRAGMA study.